SUSAN GALLIEN: Open Payments
NPI 1831354752 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 44 payments from 15 companies in 2025. Trend: 2023 $1,112 · 2024 $1,803 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $229 |
| GlaxoSmithKline, LLC. | 21 | $188 |
| Amgen Inc. | 1 | $114 |
| Baxter Healthcare | 1 | $94 |
| Viatris Specialty LLC | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Electromed, Inc. | 3 | $36 |
| GENZYME CORPORATION | 1 | $34 |
| Insmed, Inc. | 2 | $33 |
| Grifols USA, LLC | 1 | $27 |
Products named: FASENRA, TAVNEOS, TRELEGY ELLIPTA, NUCALA, AIRSUPRA, YUPELRI, WINREVAIR, SMARTVEST.
Industry payments across TX — which companies pay providers there.
